Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
By modeling the cost of achieving various clinically relevant endpoints, the analysis presents cost of control outcomes that should be intuitive to practicing diabetologists
Discuss with your provider whether continued escalation makes sense based on your specific trajectory
Addition of liraglutide to insulin in patients with type 1 diabetes: A randomized placebo-controlled clinical trial of 12 weeks
Care that fits your life, not the other way around
Combining four compounds compounds the uncertainty: potential interactions, cumulative immunogenicity, and effects of long-term exposure are all unstudied
US$ 20.42
US$ 29.90
US$ 26.24
:format(webp))
US$ 25.05
